0 Комментарии
0 Поделились
1632 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
- Войдите, чтобы отмечать, делиться и комментировать!
- Biomarkers Market Is Estimated To Witness High Growth Owing To Rising Demand In Clinical TrialsBiomarkers are biological molecules found in blood, urine or body tissues, whose presence or levels can be used as an indicator of normal biological or pathogenic process, or a response to therapeutic intervention. Biomarkers are widely used in disease diagnosis and prognosis, predictive toxicology, drug discovery and development, especially in clinical trials where they help determine the...0 Комментарии 0 Поделились 1630 Просмотры 0 предпросмотр
- Clinical Biomarkers Market: An In-Depth Exploration of the IndustryEmergen Research’s latest market research report focuses on the global Clinical Biomarkers Market, and the report provides in-depth analysis of each of its major segments. Reports about the global Clinical Biomarkers Market provide a comprehensive overview of the market, including market size, revenue growth rate, industry statistics, revenue shares among regional markets, gross profits,...0 Комментарии 0 Поделились 2107 Просмотры 0 предпросмотр
- Biomarkers: Unraveling the Significance of Molecular Markers in Precise Disease DiagnosisWhat are Biomarkers?Biological maker are molecules found in blood, other body fluids, or tissues that are indicators of a normal or abnormal process, or of a condition or disease. These molecules may be produced by the body in response to the presence of a disease or they may be the byproduct of the disease process itself. By measuring specific biological maker, doctors and researchers can gain...0 Комментарии 0 Поделились 437 Просмотры 0 предпросмотр
- Cancer Biomarkers Market Expected to Grow at a Significant Pace owing to Rising Incidence of Cancer CasesMarket Overview:Cancer biomarkers are biological molecules found in blood, urine, other body fluids or tissues that are indicators of normal or abnormal biological processes, pathogenic processes, or pharmacological responses to therapeutic interventions. Cancer biomarkers play a vital role in cancer diagnosis, prognosis, targeted therapy and monitoring treatment effectiveness or recurrence of...0 Комментарии 0 Поделились 1480 Просмотры 0 предпросмотр
- Cardiac Marker Testing Market Trends, Share Opportunities and Forecast By 2029A thorough discussion in the world class Cardiac Marker Testing report is sure to help client in studying the market on competitive landscape and has analysis of prime manufacturers, trends, opportunities, marketing strategies analysis, market effect factor analysis and consumer needs by major regions, types, and applications globally while considering the past, present and future state of the...0 Комментарии 0 Поделились 6841 Просмотры 0 предпросмотр
- Digital Biomarkers & AI/ML: Pioneering the Future of HealthcareThe healthcare sector is undergoing rapid transformation, driven by a deeper understanding of patient needs and the adoption of cutting-edge technologies. At the forefront of this evolution are digital biomarkers and AI/ML, which serve as critical enablers of next-generation healthcare solutions. This paper examines the historical development, impact, and future trajectory of these technologies...0 Комментарии 0 Поделились 69 Просмотры 0 предпросмотр
- Global Companion Diagnostic Market Set to Expand to US$ 32340 million by 2030 at 20.3 CAGRPragma Market Research and Business Consulting has published a new study titled "Companion Diagnostic Market: Size, Trends, and Insights" covering the market's dimensions, trends, and insights. Market Overview “According to the latest research study, the demand of global Companion Diagnostic Market size & share was valued at approximately US$ 8820 million in 2023 and is expected to...0 Комментарии 0 Поделились 746 Просмотры 0 предпросмотр
- PARP Inhibitor Biomarkers Market Are Estimated To Witness High Growth Owing To Rising Demand As Companion DiagnosticsPARP (Poly ADP-Ribose Polymerase) inhibitor biomarkers are used for the stratification of patients with certain cancers like breast and ovarian cancer into those likely to respond to PARP inhibitor treatment and those unlikely to respond. They play an important role as companion diagnostics alongside PARP inhibitors drugs to identify patients with homologous recombination deficiency (HRD)...0 Комментарии 0 Поделились 1184 Просмотры 0 предпросмотр